NASDAQ:GANX | EBITDA | Gain Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$5.33M
2025-12-31-$4.44M
2025-03-31-$4.35M
2024-12-31-$3.31M
2024-03-31-$4.36M
2023-12-31-$4.38M
2023-03-31-$5.21M
2022-12-31-$4.54M
2022-03-31-$3.28M
2021-12-31-$3.2M
2021-03-31-$2.46M
2020-12-31-$1.61M
2020-03-31-$510,159.00

Annual EBITDA

DateEBITDA
2025-12-31-$18.62M
2024-12-31-$20.27M
2023-12-31-$22.17M
2022-12-31-$17.71M
2021-12-31-$13.81M
2020-12-31-$3.47M